Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
35,773,173
-
Share change
-
+135,621
-
Total reported value
-
$293,344,147
-
Put/Call ratio
-
62%
-
Price per share
-
$8.20
-
Number of holders
-
104
-
Value change
-
-$8,655,319
-
Number of buys
-
58
-
Number of sells
-
28
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2017
As of 31 Dec 2017,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,773,173 shares.
The largest 10 holders included
FMR LLC, BRIDGER MANAGEMENT, LLC, BlackRock Inc., STATE STREET CORP, venBio Select Advisor LLC, FRANKLIN RESOURCES INC, Vanguard Group Inc, SENZAR ASSET MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and NORTHERN TRUST CORP.
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.